Form 4: Charles River CIO Reports Routine Stock Disposition
Statement of Changes in Beneficial Ownership
EVP and Chief Information Officer Mark Mintz disposed of 111 shares of Charles River Laboratories common stock to cover tax obligations.
Summary
- Mark Mintz, EVP and Chief Information Officer of Charles River Laboratories, executed two separate dispositions of common stock.
- On May 26, 2026, 64 shares were disposed of at a price of $160.30 per share.
- On May 27, 2026, 47 shares were disposed of at a price of $156.73 per share.
- The total number of shares disposed of was 111, leaving a remaining beneficial ownership of 7,381 shares.
- The transactions were coded as 'F', indicating the payment of tax liability by delivering or withholding securities incident to the vesting of a security-based compensation award.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and related to tax obligations rather than a discretionary sale of stock.
Positives
- The transaction reflects the vesting of equity-based compensation, which aligns the executive's interests with long-term shareholder value.
Negatives
- The reduction in direct share ownership by the Chief Information Officer.
Risks
- None identified; this is a standard administrative transaction related to tax withholding.
Future Outlook
No forward-looking guidance provided in this filing.
Industry Context
StockSavvy.ai notes that routine Form 4 filings involving tax withholding upon the vesting of equity awards are standard corporate practice and do not typically signal a change in executive sentiment regarding company performance.
Comparison to Industry Standards
- The transaction is consistent with standard executive compensation practices across the life sciences and contract research organization (CRO) sectors.
Stakeholder Impact
- Minimal impact on shareholders as the transaction is a routine tax-related equity settlement.
Next Steps
- None mentioned.
Key Dates
| Date | Description |
|---|---|
| 05/26/2026 | Date of first stock disposition transaction. |
| 05/27/2026 | Date of second stock disposition transaction and filing signature date. |
Keywords
Charles River Laboratories, CRL, Insider Trading, Form 4, Executive Compensation, Stock Disposition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.